Skip to main content
Log in

Bone marrow transplantation chemotherapy disrupts regenerative brain cell populations

  • Research Briefing
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Bone marrow transplantation causes peripheral cells to engraft the brain by an unclear mechanism. Microglia, the brain’s immune cells, lose their regenerative capacity when the bone marrow transplantation chemotherapy agent busulfan arrests their cell cycle. This causes a gradual decrease in microglial density, creating a niche for peripheral donor cells to engraft the brain and become resident macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Bulsufan-induced microglial senescence and macrophage engraftment.

References

  1. Cartier, N. et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818–823 (2009). Clinical trial using autologous bone marrow transplantation of genetically corrected cells to treat adrenoleukodystrophy.

    Article  CAS  Google Scholar 

  2. Mildner, A. et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10, 1544–1553 (2007). Study demonstrating lack of brain engraftment of bone marrow–derived cells when the brain was protected during total-body irradiation.

    Article  CAS  Google Scholar 

  3. Peake, K. et al. Bone marrow-derived cell accumulation in the spinal cord is independent of peripheral mobilization in a mouse model of amyotrophic lateral sclerosis. Front. Neurol. 8, 75 (2017). Study showing a lack of engraftment of bone marrow–derived cells after myeloablation with treosulfan, a drug that cannot penetrate the central nervous system.

    Article  Google Scholar 

  4. Shemer, A. et al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat. Commun. 9, 5206 (2018). Study showing bone marrow–derived cells in the human brain after transplantation.

    Article  CAS  Google Scholar 

  5. Buchbinder, D. et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. Bone Marrow Transpl. 53, 535–555 (2018). Study showing neurocognitive dysfunction is a complication of bone marrow transplantation.

    Article  CAS  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Sailor, K. A. et al. Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain. Nat. Med. https://doi.org/10.1038/s41591-022-01691-9 (2022).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bone marrow transplantation chemotherapy disrupts regenerative brain cell populations. Nat Med 28, 452–453 (2022). https://doi.org/10.1038/s41591-022-01722-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-01722-5

  • Springer Nature America, Inc.

Navigation